Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc S Raab

Showing results (1-10 of 177) with videos related to

Pageof 18
Sort By:
Blood|February 25, 2017
Oxygen bubbles to predict sensitivity to IMiDsMarc S Raab
Blood|January 4, 2024
Venetoclax in myeloma: to B, or not to BMarc S Raab
Clinical Lymphoma, Myeloma & Leukemia|December 17, 2024
Let's Agree to Disagree: Reflections From the Smoldering Multiple Myeloma Session at the International Myeloma Society Study SummitHira Mian, Marc S Raab
Blood|June 26, 2025
When the silence speaks: T-cell dysfunction in myelomaMirco J Friedrich, Marc S Raab
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|October 22, 2008
Induction of spindle multipolarity by centrosomal cluster inhibitionAlwin Krämer, Marc S Raab, Blanka Rebacz
Blood Cancer Discovery|October 13, 2025
Acquired and Selected: Tracking Antigen Escape during T Cell-Redirecting Therapies in Multiple MyelomaJoseph Kauer, Niels Weinhold, Marc S Raab
Therapeutische Umschau. Revue Therapeutique|November 3, 2011
[Immunostimulating drugs and cytokines]Nicola Lehners, Hartmut Goldschmidt, Marc S Raab
Journal of Cancer Research and Clinical Oncology|June 28, 2017
Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myelomaMaximilian Merz, Marc S Raab, Hartmut Goldschmidt, et al.
Hematology/Oncology Clinics of North America|January 9, 2024
Impact of Clonal Heterogeneity in Multiple MyelomaCarolina Schinke, Leo Rasche, Marc S Raab, et al.
International Journal of Molecular Sciences|March 16, 2019
The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple MyelomaLeo Rasche, K Martin Kortüm, Marc S Raab, et al.
Pageof 18

Showing results (1-10 of 177) with videos related to

Sort By:
Pageof 18
Blood|February 25, 2017
Oxygen bubbles to predict sensitivity to IMiDsMarc S Raab
Blood|January 4, 2024
Venetoclax in myeloma: to B, or not to BMarc S Raab
Clinical Lymphoma, Myeloma & Leukemia|December 17, 2024
Let's Agree to Disagree: Reflections From the Smoldering Multiple Myeloma Session at the International Myeloma Society Study SummitHira Mian, Marc S Raab
Blood|June 26, 2025
When the silence speaks: T-cell dysfunction in myelomaMirco J Friedrich, Marc S Raab
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|October 22, 2008
Induction of spindle multipolarity by centrosomal cluster inhibitionAlwin Krämer, Marc S Raab, Blanka Rebacz
Blood Cancer Discovery|October 13, 2025
Acquired and Selected: Tracking Antigen Escape during T Cell-Redirecting Therapies in Multiple MyelomaJoseph Kauer, Niels Weinhold, Marc S Raab
Therapeutische Umschau. Revue Therapeutique|November 3, 2011
[Immunostimulating drugs and cytokines]Nicola Lehners, Hartmut Goldschmidt, Marc S Raab
Journal of Cancer Research and Clinical Oncology|June 28, 2017
Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myelomaMaximilian Merz, Marc S Raab, Hartmut Goldschmidt, et al.
Hematology/Oncology Clinics of North America|January 9, 2024
Impact of Clonal Heterogeneity in Multiple MyelomaCarolina Schinke, Leo Rasche, Marc S Raab, et al.
International Journal of Molecular Sciences|March 16, 2019
The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple MyelomaLeo Rasche, K Martin Kortüm, Marc S Raab, et al.
Pageof 18